Applications of systems biology in cancer immunotherapy: from target discovery to biomarkers of clinical outcome

References

• Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 306(5696), 640–643 (2004).
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang B, Schadt EE. A systems biology approach to drug discovery. Adv. Genet. 60, 603–635 (2008).
   PubMed Web of Science ®Google Scholar
• Chuang HY, Hofree M, Ideker T. A decade of systems biology. Annu. Rev. Cell Dev. Biol. 26, 721–744 (2010).
   PubMed Web of Science ®Google Scholar
• Germain RN, Meier-Schellersheim M, Nita-Lazar A, Fraser ID. Systems biology in immunology: a computational modeling perspective. Annu. Rev. Immunol. 29, 527–585 (2011).
   PubMed Web of Science ®Google Scholar
• Stoughton RB, Friend SH. How molecular profiling could revolutionize drug discovery. Nat. Rev. Drug Discov. 4(4), 345–350 (2005).
   PubMed Web of Science ®Google Scholar
• Pujol A, Mosca R, Farrés J, Aloy P. Unveiling the role of network and systems biology in drug discovery. Trends Pharmacol. Sci. 31(3), 115–123 (2010).
   PubMed Web of Science ®Google Scholar
• Wang IM, Stone DJ, Nickle D, Loboda A, Puig O, Roberts C. Systems biology approach for new target and biomarker identification. Curr. Top. Microbiol. Immunol. 363, 169–199 (2013).
   Google Scholar
• Naylor S, Chen JY. Unraveling human complexity and disease with systems biology and personalized medicine. Per. Med. 7(3), 275–289 (2010).
   PubMed Web of Science ®Google Scholar
• Tezak Z, Ranamukhaarachchi D, Russek-Cohen E, Gutman SI. FDA perspectives on potential microarray-based clinical diagnostics. Hum. Genomics 2(4), 236–243 (2006).
   PubMedGoogle Scholar
• Golub TR, Slonim DK, Tamayo P et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 286(5439), 531–537 (1999).
   PubMed Web of Science ®Google Scholar
• Perou CM, Sørlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 406(6797), 747–752 (2000).
   PubMed Web of Science ®Google Scholar
• Alizadeh AA, Eisen MB, Davis RE et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403(6769), 503–511 (2000).
   PubMed Web of Science ®Google Scholar
• Van De Vijver MJ, He YD, Van’t Veer LJ et al. A gene-expression signature as a predictor of survival in breast cancer. N. Engl. J. Med. 347(25), 1999–2009 (2002).
   PubMed Web of Science ®Google Scholar
• Paik S, Shak S, Tang G et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N. Engl. J. Med. 351(27), 2817–2826 (2004).
   PubMed Web of Science ®Google Scholar
• Slodkowska EA, Ross JS. MammaPrint 70-gene signature: another milestone in personalized medical care for breast cancer patients. Expert Rev. Mol. Diagn. 9(5), 417–422 (2009).
   PubMed Web of Science ®Google Scholar
• Lyman GH, Cosler LE, Kuderer NM, Hornberger J. Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: an economic analysis based on prognostic and predictive validation studies. Cancer 109(6), 1011–1018 (2007).
   PubMed Web of Science ®Google Scholar
• Nakaya HI, Li S, Pulendran B. Systems vaccinology: learning to compute the behavior of vaccine induced immunity. Wiley Interdiscip. Rev. Syst. Biol. Med. 4(2), 193–205 (2012).
   PubMed Web of Science ®Google Scholar
• Pulendran B, Li S, Nakaya HI. Systems vaccinology. Immunity 33(4), 516–529 (2010).
   PubMed Web of Science ®Google Scholar
• Querec TD, Akondy RS, Lee EK et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat. Immunol. 10(1), 116–125 (2009).
   PubMed Web of Science ®Google Scholar
• Berry MP, Graham CM, McNab FW et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466(7309), 973–977 (2010).
   PubMed Web of Science ®Google Scholar
• Pascual V, Chaussabel D, Banchereau J. A genomic approach to human autoimmune diseases. Annu. Rev. Immunol. 28, 535–571 (2010).
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 144(5), 646–674 (2011).
   PubMed Web of Science ®Google Scholar
• Finn OJ. Cancer immunology. N. Engl. J. Med. 358(25), 2704–2715 (2008).
   PubMed Web of Science ®Google Scholar
• Finn OJ. Immuno-oncology: understanding the function and dysfunction of the immune system in cancer. Ann. Oncol. 23(Suppl. 8), viii6–viii9 (2012).
   PubMed Web of Science ®Google Scholar
• Kirkwood JM, Butterfield LH, Tarhini AA, Zarour H, Kalinski P, Ferrone S. Immunotherapy of cancer in 2012. CA. Cancer J. Clin. 62(5), 309–335 (2012).
   PubMed Web of Science ®Google Scholar
• Chow MT, Möller A, Smyth MJ. Inflammation and immune surveillance in cancer. Semin. Cancer Biol. 22(1), 23–32 (2012).
   PubMed Web of Science ®Google Scholar
• Mellman I, Coukos G, Dranoff G. Cancer immunotherapy comes of age. Nature 480(7378), 480–489 (2011).
   PubMed Web of Science ®Google Scholar
• Topalian SL, Weiner GJ, Pardoll DM. Cancer immunotherapy comes of age. J. Clin. Oncol. 29(36), 4828–4836 (2011).
   PubMed Web of Science ®Google Scholar
• Kasiske BL, Snyder JJ, Gilbertson DT, Wang C. Cancer after kidney transplantation in the United States. Am. J. Transplant. 4(6), 905–913 (2004).
   PubMed Web of Science ®Google Scholar
• Grulich AE, van Leeuwen MT, Falster MO, Vajdic CM. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370(9581), 59–67 (2007).
   PubMed Web of Science ®Google Scholar
• Clifford GM, Polesel J, Rickenbach M et al.; Swiss HIV Cohort. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J. Natl. Cancer Inst. 97(6), 425–432 (2005).
   PubMed Web of Science ®Google Scholar
• Galon J, Costes A, Sanchez-Cabo F et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795), 1960–1964 (2006).
   PubMed Web of Science ®Google Scholar
• Jochems C, Schlom J. Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity. Exp. Biol. Med. (Maywood) 236(5), 567–579 (2011).
   PubMed Web of Science ®Google Scholar
• Hodi FS, O’Day SJ, McDermott DF et al. Improved survival with ipilimumab in patients with metastatic melanoma. N. Engl. J. Med. 363(8), 711–723 (2010).
   PubMed Web of Science ®Google Scholar
• Kantoff PW, Higano CS, Shore ND et al.; IMPACT Study Investigators. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N. Engl. J. Med. 363(5), 411–422 (2010).
   PubMed Web of Science ®Google Scholar
• Cheever MA, Higano CS. PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine. Clin. Cancer Res. 17(11), 3520–3526 (2011).
   PubMed Web of Science ®Google Scholar
• Lipson EJ, Drake CG. Ipilimumab: an anti-CTLA-4 antibody for metastatic melanoma. Clin. Cancer Res. 17(22), 6958–6962 (2011).
   PubMed Web of Science ®Google Scholar
• Grupp SA, June CH. Adoptive cellular therapy. Curr. Top. Microbiol. Immunol. 344, 149–172 (2011).
   Google Scholar
• Chaussabel D, Pascual V, Banchereau J. Assessing the human immune system through blood transcriptomics. BMC Biol. 8, 84 (2010).
   PubMed Web of Science ®Google Scholar
• Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu. Rev. Biomed. Eng. 11, 49–79 (2009).
   PubMed Web of Science ®Google Scholar
• Stoevesandt O, Taussig MJ, He M. Protein microarrays: high-throughput tools for proteomics. Expert Rev. Proteomics 6(2), 145–157 (2009).
   PubMed Web of Science ®Google Scholar
• Holm A, Wu W, Lund-Johansen F. Antibody array analysis of labelled proteomes: how should we control specificity? N. Biotechnol. 29(5), 578–585 (2012).
   PubMedGoogle Scholar
• Metzker ML. Sequencing technologies – the next generation. Nat. Rev. Genet. 11(1), 31–46 (2010).
   PubMed Web of Science ®Google Scholar
• Ozsolak F, Milos PM. RNA sequencing: advances, challenges and opportunities. Nat. Rev. Genet. 12(2), 87–98 (2011).
   PubMed Web of Science ®Google Scholar
• Roselli M, Fernando RI, Guadagni F et al. Brachyury, a driver of the epithelial-mesenchymal transition, is overexpressed in human lung tumors: an opportunity for novel interventions against lung cancer. Clin. Cancer Res. 18(14), 3868–3879 (2012).
   PubMedGoogle Scholar
• Hopkins AL, Groom CR. The druggable genome. Nat. Rev. Drug Discov. 1(9), 727–730 (2002).
   PubMed Web of Science ®Google Scholar
• Cheever MA, Allison JP, Ferris AS et al. The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research. Clin. Cancer Res. 15(17), 5323–5337 (2009).
   PubMed Web of Science ®Google Scholar
• Miles AK, Matharoo-Ball B, Li G, Ahmad M, Rees RC. The identification of human tumour antigens: current status and future developments. Cancer Immunol. Immunother. 55(8), 996–1003 (2006).
   Google Scholar
• Morgan RA, Chinnasamy N, Abate-Daga D et al. Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy. J. Immunother. 36(2), 133–151 (2013).
   PubMed Web of Science ®Google Scholar
• Carbone DP, Ciernik IF, Kelley MJ et al. Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome. J. Clin. Oncol. 23(22), 5099–5107 (2005).
   PubMed Web of Science ®Google Scholar
• Peoples GE, Holmes JP, Hueman MT et al. Combined clinical trial results of a HER2/neu (E75) vaccine for the prevention of recurrence in high-risk breast cancer patients: US Military Cancer Institute Clinical Trials Group Study I-01 and I-02. Clin. Cancer Res. 14(3), 797–803 (2008).
   PubMed Web of Science ®Google Scholar
• Caballero OL, Chen YT. Cancer/testis (CT) antigens: potential targets for immunotherapy. Cancer Sci. 100(11), 2014–2021 (2009).
   PubMed Web of Science ®Google Scholar
• Bakker AB, Schreurs MW, de Boer AJ et al. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179(3), 1005–1009 (1994).
   PubMed Web of Science ®Google Scholar
• Kantoff PW, Schuetz TJ, Blumenstein BA et al. Overall survival analysis of a Phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer. J. Clin. Oncol. 28(7), 1099–1105 (2010).
   PubMed Web of Science ®Google Scholar
• Brentjens RJ, Curran KJ. Novel cellular therapies for leukemia: CAR-modified T cells targeted to the CD19 antigen. Hematology Am. Soc. Hematol. Educ. Program 2012, 143–151 (2012).
   PubMed Web of Science ®Google Scholar
• Loging WT, Lal A, Siu IM et al. Identifying potential tumor markers and antigens by database mining and rapid expression screening. Genome Res. 10(9), 1393–1402 (2000).
   PubMed Web of Science ®Google Scholar
• Scanlan MJ, Gordon CM, Williamson B et al. Identification of cancer/testis genes by database mining and mRNA expression analysis. Int. J. Cancer 98(4), 485–492 (2002).
   PubMed Web of Science ®Google Scholar
• Forbes SA, Bindal N, Bamford S et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res. 39(Database issue), D945–D950 (2011).
   PubMed Web of Science ®Google Scholar
• Condomines M, Hose D, Rème T et al. Gene expression profiling and real-time PCR analyses identify novel potential cancer-testis antigens in multiple myeloma. J. Immunol. 183(2), 832–840 (2009).
   Google Scholar
• Scanlan MJ, Gure AO, Jungbluth AA, Old LJ, Chen YT. Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol. Rev. 188, 22–32 (2002).
   PubMed Web of Science ®Google Scholar
• Gnjatic S, Ritter E, Büchler MW et al. Seromic profiling of ovarian and pancreatic cancer. Proc. Natl Acad. Sci. USA 107(11), 5088–5093 (2010).
   PubMed Web of Science ®Google Scholar
• Castle JC, Kreiter S, Diekmann J et al. Exploiting the mutanome for tumor vaccination. Cancer Res. 72(5), 1081–1091 (2012).
   PubMed Web of Science ®Google Scholar
• Li G, Miles A, Line A, Rees RC. Identification of tumour antigens by serological analysis of cDNA expression cloning. Cancer Immunol. Immunother. 53(3), 139–143 (2004).
   PubMed Web of Science ®Google Scholar
• Chen YT, Güre AO, Tsang S et al. Identification of multiple cancer/testis antigens by allogeneic antibody screening of a melanoma cell line library. Proc. Natl Acad. Sci. USA 95(12), 6919–6923 (1998).
   PubMed Web of Science ®Google Scholar
• Chen YT, Scanlan MJ, Sahin U et al. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl Acad. Sci. USA 94(5), 1914–1918 (1997).
   PubMed Web of Science ®Google Scholar
• Hudson ME, Pozdnyakova I, Haines K, Mor G, Snyder M. Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl Acad. Sci. USA 104(44), 17494–17499 (2007).
   PubMed Web of Science ®Google Scholar
• Liao WW, Arthur JW. Predicting peptide binding to Major Histocompatibility Complex molecules. Autoimmun. Rev. 10(8), 469–473 (2011).
   PubMedGoogle Scholar
• Lundegaard C, Lund O, Nielsen M. Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy? Expert Rev. Vaccines 11(1), 43–54 (2012).
   PubMed Web of Science ®Google Scholar
• Bozzacco L, Yu H, Zebroski HA et al. Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J. Proteome Res. 10(11), 5016–5030 (2011).
   Google Scholar
• Tan CT, Croft NP, Dudek NL, Williamson NA, Purcell AW. Direct quantitation of MHC-bound peptide epitopes by selected reaction monitoring. Proteomics 11(11), 2336–2340 (2011).
   Google Scholar
• Seliger B, Dressler SP, Massa C et al. Identification and characterization of human leukocyte antigen class I ligands in renal cell carcinoma cells. Proteomics 11(12), 2528–2541 (2011).
   PubMed Web of Science ®Google Scholar
• Weinschenk T, Gouttefangeas C, Schirle M et al. Integrated functional genomics approach for the design of patient-individual antitumor vaccines. Cancer Res. 62(20), 5818–5827 (2002).
   PubMed Web of Science ®Google Scholar
• Hawkins OE, Vangundy RS, Eckerd AM et al. Identification of breast cancer peptide epitopes presented by HLA-A*0201. J. Proteome Res. 7(4), 1445–1457 (2008).
   PubMed Web of Science ®Google Scholar
• Xu QW, Zhao W, Wang Y et al. An integrated genome-wide approach to discover tumor-specific antigens as potential immunologic and clinical targets in cancer. Cancer Res. 72(24), 6351–6361 (2012).
   PubMedGoogle Scholar
• Walter S, Weinschenk T, Stenzl A et al. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat. Med. doi:10.1038/nm.2883 (2012) (Epub ahead of print).
   PubMedGoogle Scholar
• Kreiter S, Castle JC, Türeci O, Sahin U. Targeting the tumor mutanome for personalized vaccination therapy. Oncoimmunology 1(5), 768–769 (2012).
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Horng T. Transcriptional control of the inflammatory response. Nat. Rev. Immunol. 9(10), 692–703 (2009).
   PubMed Web of Science ®Google Scholar
• Haining WN, Wherry EJ. Integrating genomic signatures for immunologic discovery. Immunity 32(2), 152–161 (2010).
   Google Scholar
• Willinger T, Freeman T, Hasegawa H, McMichael AJ, Callan MF. Molecular signatures distinguish human central memory from effector memory CD8 T cell subsets. J. Immunol. 175(9), 5895–5903 (2005).
   PubMed Web of Science ®Google Scholar
• Holmes S, He M, Xu T, Lee PP. Memory T cells have gene expression patterns intermediate between naive and effector. Proc. Natl Acad. Sci. USA 102(15), 5519–5523 (2005).
   PubMed Web of Science ®Google Scholar
• Best JA, Blair DA, Knell J et al.; Immunological Genome Project Consortium. Transcriptional insights into the CD8(+) T cell response to infection and memory T cell formation. Nat. Immunol. 14(4), 404–412 (2013).
   Google Scholar
• Gilchrist M, Thorsson V, Li B et al. Systems biology approaches identify ATF3 as a negative regulator of Toll-like receptor 4. Nature 441(7090), 173–178 (2006).
   PubMed Web of Science ®Google Scholar
• Abbas AR, Baldwin D, Ma Y et al. Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes Immun. 6(4), 319–331 (2005).
   PubMed Web of Science ®Google Scholar
• Subramanian A, Tamayo P, Mootha VK et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl Acad. Sci. USA 102(43), 15545–15550 (2005).
   PubMed Web of Science ®Google Scholar
• Hung JH, Yang TH, Hu Z, Weng Z, DeLisi C. Gene set enrichment analysis: performance evaluation and usage guidelines. Brief. Bioinformatics 13(3), 281–291 (2012).
   PubMed Web of Science ®Google Scholar
• Huang DAW, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 37(1), 1–13 (2009).
   PubMed Web of Science ®Google Scholar
• Huang H, Wu X, Sonachalam M et al. PAGED: a pathway and gene-set enrichment database to enable molecular phenotype discoveries. BMC Bioinformatics 13(Suppl. 15), S2 (2012).
   Google Scholar
• Culhane AC, Schröder MS, Sultana R et al. GeneSigDB: a manually curated database and resource for analysis of gene expression signatures. Nucleic Acids Res. 40(Database issue), D1060–D1066 (2012).
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25(1), 25–29 (2000).
   PubMed Web of Science ®Google Scholar
• Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 40(Database issue), D109–D114 (2012).
   PubMed Web of Science ®Google Scholar
• Croft D, O’Kelly G, Wu G et al. Reactome: a database of reactions, pathways and biological processes. Nucleic Acids Res. 39(Database issue), D691–D697 (2011).
   PubMed Web of Science ®Google Scholar
• Barrett T, Troup DB, Wilhite SE et al. NCBI GEO: archive for functional genomics data sets – 10 years on. Nucleic Acids Res. 39(Database issue), D1005–D1010 (2011).
   PubMed Web of Science ®Google Scholar
• Irizarry RA, Wang C, Zhou Y, Speed TP. Gene set enrichment analysis made simple. Stat. Methods Med. Res. 18(6), 565–575 (2009).
   PubMed Web of Science ®Google Scholar
• Banchereau J, Palucka AK. Dendritic cells as therapeutic vaccines against cancer. Nat. Rev. Immunol. 5(4), 296–306 (2005).
   PubMed Web of Science ®Google Scholar
• Tacken PJ, de Vries IJ, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol. 7(10), 790–802 (2007).
   PubMed Web of Science ®Google Scholar
• Palucka K, Banchereau J. Cancer immunotherapy via dendritic cells. Nat. Rev. Cancer 12(4), 265–277 (2012).
   PubMed Web of Science ®Google Scholar
• Moschella F, Bisikirska B, Maffei A et al. Gene expression profiling and functional activity of human dendritic cells induced with IFN-α-2b: implications for cancer immunotherapy. Clin. Cancer Res. 9(6), 2022–2031 (2003).
   PubMed Web of Science ®Google Scholar
• Han TH, Jin P, Ren J, Slezak S, Marincola FM, Stroncek DF. Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-γ. J. Immunother. 32(4), 399–407 (2009).
   Web of Science ®Google Scholar
• Chaussabel D, Quinn C, Shen J et al. A modular analysis framework for blood genomics studies: application to systemic lupus erythematosus. Immunity 29(1), 150–164 (2008).
   PubMed Web of Science ®Google Scholar
• Wang IM, Bett AJ, Cristescu R, Loboda A, ter Meulen J. Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates. Microb. Biotechnol. 5(2), 177–187 (2012).
   PubMed Web of Science ®Google Scholar
• Painter MW, Davis S, Hardy RR, Mathis D, Benoist C; Immunological Genome Project Consortium. Transcriptomes of the B and T lineages compared by multiplatform microarray profiling. J. Immunol. 186(5), 3047–3057 (2011).
   Google Scholar
• Robbins SH, Walzer T, Dembélé D et al. Novel insights into the relationships between dendritic cell subsets in human and mouse revealed by genome-wide expression profiling. Genome Biol. 9(1), R17 (2008).
   PubMed Web of Science ®Google Scholar
• Chan CW, Crafton E, Fan HN et al. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12(2), 207–213 (2006).
   PubMed Web of Science ®Google Scholar
• Haining WN, Angelosanto J, Brosnahan K et al. High-throughput gene expression profiling of memory differentiation in primary human T cells. BMC Immunol. 9, 44 (2008).
   Google Scholar
• Lehtonen A, Ahlfors H, Veckman V, Miettinen M, Lahesmaa R, Julkunen I. Gene expression profiling during differentiation of human monocytes to macrophages or dendritic cells. J. Leukoc. Biol. 82(3), 710–720 (2007).
   PubMed Web of Science ®Google Scholar
• Shen-Orr SS, Tibshirani R, Khatri P et al. Cell type-specific gene expression differences in complex tissues. Nat. Methods 7(4), 287–289 (2010).
   PubMed Web of Science ®Google Scholar
• Gajewski TF, Louahed J, Brichard VG. Gene signature in melanoma associated with clinical activity: a potential clue to unlock cancer immunotherapy. Cancer J. 16(4), 399–403 (2010).
   PubMed Web of Science ®Google Scholar
• Ji RR, Chasalow SD, Wang L et al. An immune-active tumor microenvironment favors clinical response to ipilimumab. Cancer Immunol. Immunother. 61(7), 1019–1031 (2012).
   PubMed Web of Science ®Google Scholar
• Prins RM, Soto H, Konkankit V et al. Gene expression profile correlates with T-cell infiltration and relative survival in glioblastoma patients vaccinated with dendritic cell immunotherapy. Clin. Cancer Res. 17(6), 1603–1615 (2011).
   PubMed Web of Science ®Google Scholar
• Tyagi P, Mirakhur B. MAGRIT: the largest-ever Phase III lung cancer trial aims to establish a novel tumor-specific approach to therapy. Clin. Lung Cancer 10(5), 371–374 (2009).
   PubMed Web of Science ®Google Scholar
• Ribas A, Timmerman JM, Butterfield LH, Economou JS. Determinant spreading and tumor responses after peptide-based cancer immunotherapy. Trends Immunol. 24(2), 58–61 (2003).
   PubMed Web of Science ®Google Scholar
• Vanderlugt CL, Miller SD. Epitope spreading in immune-mediated diseases: implications for immunotherapy. Nat. Rev. Immunol. 2(2), 85–95 (2002).
   PubMed Web of Science ®Google Scholar
• Yuan J, Adamow M, Ginsberg BA et al. Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab. Proc. Natl Acad. Sci. USA 108(40), 16723–16728 (2011).
   PubMed Web of Science ®Google Scholar
• Nesslinger NJ, Ng A, Tsang KY et al. A viral vaccine encoding prostate-specific antigen induces antigen spreading to a common set of self-proteins in prostate cancer patients. Clin. Cancer Res. 16(15), 4046–4056 (2010).
   PubMedGoogle Scholar
• Kwek SS, Dao V, Roy R et al. Diversity of antigen-specific responses induced in vivo with CTLA-4 blockade in prostate cancer patients. J. Immunol. 189(7), 3759–3766 (2012).
   PubMed Web of Science ®Google Scholar
• Disis ML, Goodell V, Schiffman K, Knutson KL. Humoral epitope-spreading following immunization with a HER-2/neu peptide based vaccine in cancer patients. J. Clin. Immunol. 24(5), 571–578 (2004).
   PubMed Web of Science ®Google Scholar
• Mittendorf EA, Gurney JM, Storrer CE, Shriver CD, Ponniah S, Peoples GE. Vaccination with a HER2/neu peptide induces intra- and inter-antigenic epitope spreading in patients with early stage breast cancer. Surgery 139(3), 407–418 (2006).
   PubMed Web of Science ®Google Scholar
• Wierecky J, Müller MR, Wirths S et al. Immunologic and clinical responses after vaccinations with peptide-pulsed dendritic cells in metastatic renal cancer patients. Cancer Res. 66(11), 5910–5918 (2006).
   PubMed Web of Science ®Google Scholar
• Butterfield LH, Ribas A, Dissette VB et al. Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma. Clin. Cancer Res. 9(3), 998–1008 (2003).
   PubMed Web of Science ®Google Scholar
• Nguyen MC, Tu GH, Koprivnikar KE, Gonzalez-Edick M, Jooss KU, Harding TC. Antibody responses to galectin-8, TARP and TRAP1 in prostate cancer patients treated with a GM-CSF-secreting cellular immunotherapy. Cancer Immunol. Immunother. 59(9), 1313–1323 (2010).
   Google Scholar
• Bamshad MJ, Ng SB, Bigham AW et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat. Rev. Genet. 12(11), 745–755 (2011).
   PubMed Web of Science ®Google Scholar
• Alkan C, Coe BP, Eichler EE. Genome structural variation discovery and genotyping. Nat. Rev. Genet. 12(5), 363–376 (2011).
   PubMed Web of Science ®Google Scholar
• Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 11(10), 685–696 (2010).
   PubMed Web of Science ®Google Scholar
• Wang C, Sanders CM, Yang Q et al. High throughput sequencing reveals a complex pattern of dynamic interrelationships among human T cell subsets. Proc. Natl Acad. Sci. USA 107(4), 1518–1523 (2010).
   PubMed Web of Science ®Google Scholar
• Warren RL, Freeman JD, Zeng T et al. Exhaustive T-cell repertoire sequencing of human peripheral blood samples reveals signatures of antigen selection and a directly measured repertoire size of at least 1 million clonotypes. Genome Res. 21(5), 790–797 (2011).
   PubMed Web of Science ®Google Scholar
• Robins HS, Campregher PV, Srivastava SK et al. Comprehensive assessment of T-cell receptor β-chain diversity in αβ T cells. Blood 114(19), 4099–4107 (2009).
   PubMed Web of Science ®Google Scholar
• Boyd SD, Marshall EL, Merker JD et al. Measurement and clinical monitoring of human lymphocyte clonality by massively parallel VDJ pyrosequencing. Sci. Transl. Med. 1(12), 12ra23 (2009).
   PubMed Web of Science ®Google Scholar
• Freeman JD, Warren RL, Webb JR, Nelson BH, Holt RA. Profiling the T-cell receptor β-chain repertoire by massively parallel sequencing. Genome Res. 19(10), 1817–1824 (2009).
   PubMed Web of Science ®Google Scholar
• Murugan A, Mora T, Walczak AM, Callan CG Jr. Statistical inference of the generation probability of T-cell receptors from sequence repertoires. Proc. Natl Acad. Sci. USA 109(40), 16161–16166 (2012).
   Google Scholar
• Baum PD, Venturi V, Price DA. Wrestling with the repertoire: the promise and perils of next generation sequencing for antigen receptors. Eur. J. Immunol. 42(11), 2834–2839 (2012).
   Google Scholar
• Bolotin DA, Mamedov IZ, Britanova OV et al. Next generation sequencing for TCR repertoire profiling: platform-specific features and correction algorithms. Eur. J. Immunol. 42(11), 3073–3083 (2012).
   PubMed Web of Science ®Google Scholar
• Wu D, Sherwood A, Fromm JR et al. High-throughput sequencing detects minimal residual disease in acute T lymphoblastic leukemia. Sci. Transl. Med. 4(134), 134ra63 (2012).
   Google Scholar
• Logan AC, Gao H, Wang C et al. High-throughput VDJ sequencing for quantification of minimal residual disease in chronic lymphocytic leukemia and immune reconstitution assessment. Proc. Natl Acad. Sci. USA 108(52), 21194–21199 (2011).
   PubMed Web of Science ®Google Scholar
• Grupp SA, Prak EL, Boyer J et al. Adoptive transfer of autologous T cells improves T-cell repertoire diversity and long-term B-cell function in pediatric patients with neuroblastoma. Clin. Cancer Res. 18(24), 6732–6741 (2012).
   PubMed Web of Science ®Google Scholar
• Chervin AS, Stone JD, Soto CM et al. Design of T-cell receptor libraries with diverse binding properties to examine adoptive T-cell responses. Gene Ther. doi:10.1038/gt.2012.80 (2012) (Epub ahead of print).
   Google Scholar
• Disis ML. Immunologic biomarkers as correlates of clinical response to cancer immunotherapy. Cancer Immunol. Immunother. 60(3), 433–442 (2011).
   PubMed Web of Science ®Google Scholar
• Komatsu N, Matsueda S, Tashiro K et al. Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination. Cancer 118(12), 3208–3221 (2012).
   PubMed Web of Science ®Google Scholar
• Ross RW, Galsky MD, Scher HI et al. A whole-blood RNA transcript-based prognostic model in men with castration–resistant prostate cancer: a prospective study. Lancet Oncol. 13(11), 1105–1113 (2012).
   PubMedGoogle Scholar
• Olmos D, Brewer D, Clark J et al. Prognostic value of blood mRNA expression signatures in castration-resistant prostate cancer: a prospective, two-stage study. Lancet Oncol. 13(11), 1114–1124 (2012).
   PubMed Web of Science ®Google Scholar
• Breunis WB, Tarazona-Santos E, Chen R, Kiley M, Rosenberg SA, Chanock SJ. Influence of cytotoxic T lymphocyte-associated antigen 4 (CTLA4) common polymorphisms on outcome in treatment of melanoma patients with CTLA-4 blockade. J. Immunother. 31(6), 586–590 (2008).
   PubMed Web of Science ®Google Scholar
• Liu D, O’Day SJ, Yang D et al. Impact of gene polymorphisms on clinical outcome for stage IV melanoma patients treated with biochemotherapy: an exploratory study. Clin. Cancer Res. 11(3), 1237–1246 (2005).
   PubMed Web of Science ®Google Scholar
• Cortes A, Brown MA. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13(1), 101 (2011).
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Ansell SM, Fredericksen ZS et al. Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma. Blood 110(13), 4455–4463 (2007).
   PubMed Web of Science ®Google Scholar
• Cheung VG, Spielman RS. Genetics of human gene expression: mapping DNA variants that influence gene expression. Nat. Rev. Genet. 10(9), 595–604 (2009).
   PubMed Web of Science ®Google Scholar
• Schadt EE, Molony C, Chudin E et al. Mapping the genetic architecture of gene expression in human liver. PLoS Biol. 6(5), e107 (2008).
   PubMed Web of Science ®Google Scholar
• Nicolae DL, Gamazon E, Zhang W, Duan S, Dolan ME, Cox NJ. Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet. 6(4), e1000888 (2010).
   PubMed Web of Science ®Google Scholar
• Fox BA, Schendel DJ, Butterfield LH et al. Defining the critical hurdles in cancer immunotherapy. J. Transl. Med. 9(1), 214 (2011).
   PubMedGoogle Scholar
• Butterfield LH, Disis ML, Khleif SN, Balwit JM, Marincola FM. Immuno-oncology biomarkers 2010 and beyond: perspectives from the iSBTc/SITC biomarker task force. J. Transl. Med. 8, 130 (2010).
   PubMedGoogle Scholar
• Hoos A, Eggermont AM, Janetzki S et al. Improved endpoints for cancer immunotherapy trials. J. Natl. Cancer Inst. 102(18), 1388–1397 (2010).
   PubMed Web of Science ®Google Scholar
• Madan RA, Gulley JL, Fojo T, Dahut WL. Therapeutic cancer vaccines in prostate cancer: the paradox of improved survival without changes in time to progression. Oncologist 15(9), 969–975 (2010).
   PubMed Web of Science ®Google Scholar
• Butterfield LH, Palucka AK, Britten CM et al. Recommendations from the iSBTc-SITC/FDA/NCI Workshop on Immunotherapy Biomarkers. Clin. Cancer Res. 17(10), 3064–3076 (2011).
   PubMedGoogle Scholar
• Sheikh NA, Petrylak D, Kantoff PW et al. Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized Phase 3 clinical trials in men with castration-resistant prostate cancer. Cancer Immunol. Immunother. 62(1), 137–147 (2013).
   PubMed Web of Science ®Google Scholar
• Lonchay C, van der Bruggen P, Connerotte T et al. Correlation between tumor regression and T cell responses in melanoma patients vaccinated with a MAGE antigen. Proc. Natl Acad. Sci. USA 101(Suppl. 2), 14631–14638 (2004).
   PubMed Web of Science ®Google Scholar
• Geiss GK, Bumgarner RE, Birditt B et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat. Biotechnol. 26(3), 317–325 (2008).
   PubMed Web of Science ®Google Scholar
• Philippi S, Köhler J. Addressing the problems with life-science databases for traditional uses and systems biology. Nat. Rev. Genet. 7(6), 482–488 (2006).
   Google Scholar
• Chaussabel D, Ueno H, Banchereau J, Quinn C. Data management: it starts at the bench. Nat. Immunol. 10(12), 1225–1227 (2009).
   PubMed Web of Science ®Google Scholar
• Disis ML, Slattery JT. The road we must take: multidisciplinary team science. Sci. Transl. Med. 2(22), 22cm9 (2010).
   PubMed Web of Science ®Google Scholar
• Hawkins RD, Hon GC, Ren B. Next-generation genomics: an integrative approach. Nat. Rev. Genet. 11(7), 476–486 (2010).
   PubMed Web of Science ®Google Scholar
• Hwang D, Rust AG, Ramsey S et al. A data integration methodology for systems biology. Proc. Natl Acad. Sci. USA 102(48), 17296–17301 (2005).
   PubMed Web of Science ®Google Scholar
• Schadt EE, Björkegren JL. NEW: network-enabled wisdom in biology, medicine, and health care. Sci. Transl. Med. 4(115), 115rv1 (2012).
   PubMed Web of Science ®Google Scholar